Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Rocky Mountain Cancer Centers

     
Denver , CO 80218
USA

 

Principal Investigator:
 Allen Cohn, MD
Contact:
 Silva Mosher 303-285-5081 silva.mosher@usoncology.com
Activation Status of this Site:
 Closed
Notes about this Site:
Rocky Mountain Cancer Centers Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.